Technical Trend Overview and Price Movement
Lupin’s current price stands at ₹2,497.75, marginally up by 0.07% from the previous close of ₹2,496.05. The stock traded within a range of ₹2,482.85 to ₹2,509.10 today, nearing its 52-week high of ₹2,526.00, while comfortably above its 52-week low of ₹1,838.65. This price action reflects resilience amid a mixed technical backdrop.
The broader technical trend has shifted from bullish to mildly bullish, signalling a tempering of upward momentum but not a reversal. This subtle change suggests that while the stock remains in an uptrend, the pace of gains may moderate, requiring investors to monitor momentum indicators closely.
MACD and Moving Averages: Bullish Signals Persist
The Moving Average Convergence Divergence (MACD) indicator remains bullish on both weekly and monthly timeframes, reinforcing the presence of positive momentum. This sustained MACD bullishness indicates that the stock’s short-term momentum is aligned with its longer-term trend, a favourable sign for continuation of gains.
Complementing this, daily moving averages also maintain a bullish stance, suggesting that recent price action is supported by underlying trend strength. The alignment of daily moving averages with MACD’s positive signals provides a solid technical foundation for Lupin’s price stability and potential upside.
RSI and KST Indicators Signal Caution
Contrasting the bullish MACD and moving averages, the Relative Strength Index (RSI) presents a mixed picture. While the weekly RSI shows no definitive signal, the monthly RSI is bearish, indicating potential overbought conditions or weakening momentum over the longer term. This divergence between weekly and monthly RSI readings suggests that while short-term momentum remains intact, longer-term strength may be waning.
Similarly, the Know Sure Thing (KST) indicator is mildly bearish on both weekly and monthly charts. This mild bearishness in KST, a momentum oscillator that smooths price changes, signals a possible slowdown in the stock’s upward momentum, urging investors to exercise caution and watch for confirmation of trend direction.
Bollinger Bands and Dow Theory: Mixed but Leaning Bullish
Bollinger Bands indicate a mildly bullish stance on the weekly timeframe and a bullish stance on the monthly timeframe. This suggests that price volatility remains contained within an upward trending channel, supporting the case for continued gains, albeit with some caution on weekly fluctuations.
Dow Theory analysis reveals no clear trend on the weekly chart but confirms a bullish trend on the monthly chart. This mixed signal underscores the importance of timeframe perspective when analysing Lupin’s technical outlook, with longer-term trends favouring bulls while shorter-term trends remain uncertain.
On-Balance Volume and Volume Trends
On-Balance Volume (OBV) analysis shows no trend on the weekly timeframe and a mildly bearish trend on the monthly timeframe. This suggests that volume support for price gains is currently weak or declining over the longer term, which could limit the sustainability of upward price moves if selling pressure intensifies.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
Comparative Returns and Market Context
Lupin’s price momentum is further contextualised by its impressive returns relative to the Sensex. Over the past week, Lupin gained 0.21% while the Sensex declined by 0.85%. The one-month return for Lupin stands at 8.94%, significantly outperforming the Sensex’s 2.77% gain. Year-to-date, Lupin has surged 18.26%, contrasting sharply with the Sensex’s 8.92% decline.
Over longer horizons, Lupin’s outperformance is even more pronounced. The stock has delivered a 32.30% return over the past year versus a 5.92% loss for the Sensex. Over three years, Lupin’s return of 168.43% dwarfs the Sensex’s 18.39%, while five-year gains of 114.46% also substantially exceed the benchmark’s 47.09%. However, over a ten-year period, Lupin’s 51.47% return trails the Sensex’s 179.04%, reflecting the stock’s more recent acceleration in performance.
Mojo Score and Analyst Ratings
MarketsMOJO assigns Lupin a Mojo Score of 77.0, reflecting a solid Buy rating. This represents a slight downgrade from a previous Strong Buy rating as of 13 July 2026, signalling a modest tempering of enthusiasm amid the evolving technical signals. Lupin’s mid-cap market capitalisation classification aligns with its growth profile and sector positioning within Pharmaceuticals & Biotechnology.
The downgrade from Strong Buy to Buy is consistent with the technical trend shift from bullish to mildly bullish, indicating that while Lupin remains an attractive investment, investors should be mindful of potential volatility and mixed momentum signals.
Lupin Ltd. caught your attention? Explore our comprehensive research report with in-depth analysis of this mid-cap Pharmaceuticals & Biotechnology stock – fundamentals, valuations, financials, and technical outlook!
- - Comprehensive research report
- - In-depth mid-cap analysis
- - Valuation assessment included
Investor Takeaway and Outlook
In summary, Lupin Ltd. presents a technically nuanced picture. The stock’s price momentum remains positive, supported by bullish MACD readings and daily moving averages, while Bollinger Bands and Dow Theory trends lean bullish on longer timeframes. However, caution is warranted given the bearish monthly RSI and KST indicators, alongside weakening volume trends as indicated by OBV.
Investors should consider Lupin’s strong relative performance against the Sensex and its solid Mojo Score of 77.0, which supports a Buy rating. The recent downgrade from Strong Buy reflects a prudent reassessment of momentum dynamics rather than a fundamental shift in the company’s prospects.
Given the mixed signals, a balanced approach is advisable. Investors may favour accumulation on dips while monitoring key technical levels and momentum indicators for signs of trend confirmation or reversal. Lupin’s proximity to its 52-week high near ₹2,526.00 suggests that a breakout above this level could reignite bullish momentum, whereas a sustained drop below recent support levels may signal a deeper correction.
Overall, Lupin remains a compelling mid-cap stock within the Pharmaceuticals & Biotechnology sector, with technical indicators suggesting a cautiously optimistic outlook for the near term.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
